SABS
SAB BiotherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SABS vs peer average
69/100
SABS vs. peer average (C vs. D)
Grade spread
B 1 · C 2 · D 2 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
FULC is the first available peer comparator.
Same-sector, similar-market-cap biotech comparator; stage, indication, and catalyst fit are not verified, so use only as a loose volatility reference.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SABS
SAB Biotherapeutics
FULC
Fulcrum Therapeutics
Grade
C
C
Momentum
12
38
Value
43
58
Sentiment
75
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs FULC
SABS / FULC
Grade Position
In line
SABS vs. peer average (C vs. D)
69/100
Momentum
12
FULCValue
43
FULCSentiment
75
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SABS
FULC is the first peer returned for this comparison set.